Osteoarthritis and Cartilage

该期刊政策规定，作者在写作过程中使用生成式人工智能或AI辅助技术时，只能用于改善可读性和语言表达，且须在人工监督和控制下进行，并仔细审查和编辑AI生成的内容，因为AI可能产生看似权威但错误、不完整或有偏见的结果。 模型中文摘要

The below guidance only refers to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process. Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human o…

该期刊政策规定，稿件提交后一般不考虑作者身份变更，作者须在首次投稿时提供确定的作者名单；投稿前所有作者必须列入稿件并在投稿系统中录入其信息，任何作者姓名的增删或排序调整只能在稿件被接受之前且经期刊编辑批准后进行。 模型中文摘要

The editors of this journal generally will not consider changes to authorship once a manuscript has been submitted. It is important that authors carefully consider the authorship list and order of authors and provide a definitive author list at original submission. The policy of this journal around authorship changes: All authors must be listed in the manuscript and their details entered into the …

该期刊政策规定，在稿件正文末尾以“利益竞争声明”为小标题，每位作者必须披露任何可能不当影响其工作和结论的与他人或组织的财务和个人关系，例如雇佣、咨询、持股、酬金、有偿专家证言、专利申请/注册以及研究资助等潜在利益冲突。 模型中文摘要

At the end of the manuscript text, under a subheading "Competing interest statement" every author must disclose any financial and personal relationships with other people or organizations that could potentially and inappropriately influence (bias) their work and conclusions. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testi…

该期刊政策规定，编辑严肃对待一切可能的学术不端行为，遵循出版伦理委员会（COPE）、世界医学编辑协会（WAME）和国际医学期刊编辑委员会（ICMJE）的指导与定义，投稿稿件将接受随机抽取的计算机化查重与冗余检测，使用预印本服务被视为可接受，不视为冗余发表。 模型中文摘要

The editors of Osteoarthritis and Cartilage consider very seriously all possible forms of misconduct. We follow guidance and definitions provided by e.g. the Committee on Publication Ethics (http://publicationethics.org/) the World Association of Medical Editors (http://www.wame.org/) and the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/). Submitted manuscripts …

该期刊政策规定，文章被接受后，作者须签署“期刊出版协议”，以确保信息得到最广泛的传播，协议确认函（或表格/在线版链接）将发送给通讯作者。 模型中文摘要

Upon acceptance of an article, authors will be asked to sign a "Journal Publishing Agreement" (for more information on this and copyright see https://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail (or letter) will be sent to the corresponding author confirming receipt of the manuscript together with a "Journal Publis…

该期刊政策规定，期刊为作者提供发表其研究的选择（如订阅模式或开放获取模式）。 模型中文摘要

This journal offers authors a choice in publishing their research:

该期刊政策规定，所有投稿稿件均接受内部和/或外部同行评审，相当比例的稿件在由主编之一及一名或多名编辑进行首次评审后，因原创性不足、科学缺陷或缺乏对读者重要的信息而被拒稿，该决定将在1-2周内通知作者。 模型中文摘要

All manuscripts submitted to Osteoarthritis and Cartilage are peer reviewed, internally and or externally. A significant proportion of the submitted articles are rejected after a first review by one of the editors-in-chief and one or more editors for reasons of insufficient originality, scientific flaws, or an absence of message important to the readers of the Journal. This decision is forwarded t…

该期刊政策规定，作为考虑发表临床试验的条件，临床试验必须在公共试验注册机构（如 ClinicalTrials.gov 或 ISRCTN）进行注册，此要求采纳自国际医学期刊编辑委员会（ICMJE）的提议。 模型中文摘要

Osteoarthritis and Cartilage has adopted the proposal from the International Committee of Medical Journal Editors (ICMJE) which requires, as a condition of consideration for publication of clinical trials, registration in a public trials registry such as http://www.clinicaltrials.gov/ or http://www.isrctn.com/.